Spreadex Market Update

Asian equity benchmarks marginally softer in early trading



Asian equity benchmarks were marginally softer in early trading on Monday morning in sympathy of ongoing Ukraine concerns. Global risk appetite can’t help be bound by the consequences of a potentially very global problem. The dollar has traded generally lighter against most pairings. Meanwhile, European stock indices are looking to open ahead of Friday’s close.

Here in London, we’re digesting news that Ophir Energy (OPHR) is no longer considering making a bid for Premier Oil (PMO). A story broke in The Times over the weekend that PMO had been a target for some time. Buyers that helped edge up shares by more than 4 percent on Friday will be closely following prices on the open. The US giant Pfizer has today confirmed its approach to AstraZeneca (AZN), concluding the chain of information that has seen its shares more than 10 percent higher over the last week.

Investors looking for Macro flow will turn to US pending home sales out at 3pm (BST). Economists are forecasting a 1 percent expansion on the last print of -0.8 percent.

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.